Why the study?
Does enoxaparin reduce the incidence of deep venous thrombosis in patients who had knee arthroplasty compared to adjusted-dose warfarin?
Does enoxaparin reduce the incidence of deep venous thrombosis in patients who had knee arthroplasty compared to adjusted-dose warfarin?
Postoperative fixed-dose enoxaparin is more effective than adjusted-dose warfarin for preventing venographic deep venous thrombosis after knee arthroplasty, with no significant difference in major bleeding.
Answers are grounded in this paper and cite their sources.
Supports preferring fixed-dose enoxaparin over adjusted-dose warfarin for post-knee arthroplasty VTE prophylaxis; reinforces LMWH superiority in orthopedic RCTs.
OBJECTIVE: To compare the effectiveness and safety of fixed-dose enoxaparin and adjusted dose warfarin in preventing venous thromboembolism after knee arthroplasty. DESIGN: A randomized, double-blind controlled trial. SETTING: 8 university hospitals. PATIENTS: 670 consecutive patients who had knee arthroplasty. INTERVENTION: Patients were randomly assigned to receive enoxaparin (30 mg subcutaneously every 12 hours) or adjusted-dose warfarin (international normalized ratio, 2.0 to 3.0). Both regimens were started after surgery. MEASUREMENTS: The primary end point was the incidence of deep venous thrombosis in patients with adequate bilateral venograms; the secondary end point was hemorrhage. RESULTS: Among the 417 patients with adequate venograms, 109 of 211 warfarin recipients (51.7%) had deep venous thrombosis compared with 76 of 206 enoxaparin recipients (36.9%) (P = 0.003). The absolute risk difference was 14.8% in favor of enoxaparin (95% Cl, 5.3% to 24.1%) Twenty-two warfarin recipients (10.4%) and 24 enoxaparin recipients (11.7%) had proximal venous thrombosis (P>0.2). The absolute risk difference was 1.2% in favor of warfarin (Cl, -7.2% to 4.8%). The incidence of major bleeding was 1.8% (6 of 334 patients) in the warfarin group and 2.1% (7 of 336 patients) in the enoxaparin group (P>0.2). The absolute risk difference was 0.3% in favor of warfarin (Cl, -2.4% to 1.8%). CONCLUSIONS: A postoperative, fixed-dose enoxaparin regimen is more effective than adjusted-dose warfarin in preventing deep venous thrombosis after knee arthroplasty. No differences were seen in the incidence of proximal venous thrombosis or clinically overt hemorrhage.
No takes yet. Share an insight, caveat, or question.
Jacques R. Leclerc (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: